Page last updated: 2024-08-21

hematoporphyrin and Bile Duct Cancer

hematoporphyrin has been researched along with Bile Duct Cancer in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jin, H; Lou, Q; Shen, H; Yang, J; Zhang, X	1
Ortner, MA	1
Fu, QF; Liu, LX; Pan, SH; Wang, CY; Wang, JB	1
Gerhardt, T; Heller, J; Höblinger, A; Rings, D; Sauerbruch, T; Schepke, M	1
Apel, D; Arnold, JC; Jakobs, R; Riemann, JF; Zoepf, T	1

Reviews

1 review(s) available for hematoporphyrin and Bile Duct Cancer

Article	Year
Photodynamic therapy for cholangiocarcinoma: overview and new developments. Current opinion in gastroenterology, 2009, Volume: 25, Issue:5 Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Hematoporphyrins; Humans; Interleukin-6; Mesoporphyrins; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Stents	2009

Trials

2 trial(s) available for hematoporphyrin and Bile Duct Cancer

Article	Year
Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: A prospective study. Photodiagnosis and photodynamic therapy, 2016, Volume: 16 Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; China; Cholangiocarcinoma; Combined Modality Therapy; Female; Hematoporphyrins; Humans; Jaundice; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prevalence; Prospective Studies; Risk Factors; Stents; Survival Rate; Treatment Outcome	2016
Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. The American journal of gastroenterology, 2005, Volume: 100, Issue:11 Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bilirubin; Catheters, Indwelling; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Drainage; Female; Follow-Up Studies; Hematoporphyrins; Humans; Laser Therapy; Male; Middle Aged; Neoplasm Staging; Palliative Care; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Survival Rate	2005

Article

Year

Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: A prospective study.

Photodiagnosis and photodynamic therapy, 2016, Volume: 16

Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; China; Cholangiocarcinoma; Combined Modality Therapy; Female; Hematoporphyrins; Humans; Jaundice; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prevalence; Prospective Studies; Risk Factors; Stents; Survival Rate; Treatment Outcome

2016

Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.

The American journal of gastroenterology, 2005, Volume: 100, Issue:11

Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bilirubin; Catheters, Indwelling; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Drainage; Female; Follow-Up Studies; Hematoporphyrins; Humans; Laser Therapy; Male; Middle Aged; Neoplasm Staging; Palliative Care; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Survival Rate

2005

Other Studies

2 other study(ies) available for hematoporphyrin and Bile Duct Cancer

Article	Year
Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939. Neoplasma, 2010, Volume: 57, Issue:1 Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Caspase 3; Cell Line, Tumor; Cholangiocarcinoma; Cytochromes c; Hematoporphyrins; Humans; Photochemotherapy	2010
Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma. Zeitschrift fur Gastroenterologie, 2010, Volume: 48, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Camptothecin; Cholangiocarcinoma; Cholestasis, Intrahepatic; Combined Modality Therapy; Deoxycytidine; Duodenoscopy; Feasibility Studies; Female; Fluorouracil; Gemcitabine; Hematoporphyrins; Humans; Irinotecan; Male; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Stents; Treatment Outcome	2010

Article

Year

Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939.

Neoplasma, 2010, Volume: 57, Issue:1

Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Caspase 3; Cell Line, Tumor; Cholangiocarcinoma; Cytochromes c; Hematoporphyrins; Humans; Photochemotherapy

2010

Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma.

Zeitschrift fur Gastroenterologie, 2010, Volume: 48, Issue:1

Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Camptothecin; Cholangiocarcinoma; Cholestasis, Intrahepatic; Combined Modality Therapy; Deoxycytidine; Duodenoscopy; Feasibility Studies; Female; Fluorouracil; Gemcitabine; Hematoporphyrins; Humans; Irinotecan; Male; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Stents; Treatment Outcome

2010